Apr 24, 2001
No fewer than six of this year's inductees to the prestigious American Society for Clinical Investigation (ASCI) are from Weill Cornell Medical College. They were recently honored at a special reception held at Weill Cornell's Griffis Faculty Club and hosted by Dr. Antonio M. Gotto, Jr., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College, and Dr. Herbert Pardes, President and CEO of NewYork-Presbyterian Hospital.
The six inductees and their areas of research are:
Ethel Cesarman, M.D., Ph.D., Associate Professor of Pathology, has studied cancer-causing viruses, especially in patients with AIDS who are susceptible to lymphoma and Kaposi's sarcoma.
Andrew J. Dannenberg, M.D., Professor of Medicine, is known for his investigation of COX-2 inhibitors and cancer.
Steven A. Goldman, M.D., Ph.D., Professor of Neurology and Neuroscience, conducts research into demyelinating diseases such as multiple sclerosis.
Lionel B. Ivashkiv, M.D., Associate Professor of Medicine and Associate Professor of Immunology, has studied the regulation of cytokine-signaling in inflammatory diseases.
David M. Nanus, M.D., Associate Professor of Medicine, Associate Professor of Urology, and Director of the Genito-Urinary Oncology Program, is a genito-urinary oncologist with expertise in clinical and laboratory aspects of prostate cancer and kidney cancer.
Shahin Rafii, M.D., Assistant Professor of Medicine, is interested in stem-cell biology and tumor angiogenesis.
The American Society for Clinical Investigation (ASCI), established in 1908, is composed of 2,600 physician-scientists from all medical specialties, who are elected to the Society for their outstanding records of scholarly achievement in biomedical research. It is quite unusual for a medical school to have as many as six scientists inducted into ASCI at a single time.